Author
Michigan Center for Translational PathologyORCID 0000-0002-2337-7439Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Ryan James Rebernick, Liat Hammer, Mahnoor Naseer Gondal…·Marcin Cieslik
This study identifies genomic drivers of progression and therapeutic outcomes in mCRPC and develops a multi-omic classifier to predict patient survival across multiple therapies.
Justin Wagner, Ayşe Gökçe Keşküş, Keisuke K. Oshima…·Justin M. Zook
This paper presents near-complete, haplotype-resolved assemblies of a pancreatic cancer genome and normal tissue, identifying extensive somatic variants and epigenetic changes in previously excluded regions.
Jean Ching-Yi Tien, Jie Luo, Yu Chang…·Arul M. Chinnaiyan
This study shows CDK12 loss drives prostate cancer development and identifies CDK13 as a therapeutic target through paralog-based synthetic lethality in CDK12-mutant tumors.